Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1392212-91-7 | MDL No. : | MFCD08544298 |
Formula : | C10H11ClF3NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CZTHXVIPUSKPKD-UHFFFAOYSA-N |
M.W : | 253.65 | Pubchem ID : | 71432257 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 55.27 |
TPSA : | 35.25 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.0 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.6 |
Log Po/w (WLOGP) : | 4.12 |
Log Po/w (MLOGP) : | 2.42 |
Log Po/w (SILICOS-IT) : | 2.54 |
Consensus Log Po/w : | 2.33 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.26 |
Solubility : | 0.139 mg/ml ; 0.000547 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.99 |
Solubility : | 0.26 mg/ml ; 0.00102 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.27 |
Solubility : | 0.136 mg/ml ; 0.000535 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.74 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
[ 886368-62-3 ]
2,2,2-Trifluoro-1-(2-methoxyphenyl)ethanamine
Similarity: 0.78
[ 1810074-61-3 ]
(R)-6-(Trifluoromethoxy)chroman-4-amine hydrochloride
Similarity: 0.76
[ 2222471-40-9 ]
(S)-2,2,2-Trifluoro-1-(3-methoxyphenyl)ethanamine hydrochloride
Similarity: 0.75
[ 1260609-97-9 ]
(S)-6-Fluorochroman-4-amine hydrochloride
Similarity: 0.75
[ 1266230-22-1 ]
(R)-7-Fluorochroman-4-amine hydrochloride
Similarity: 0.75
[ 886368-62-3 ]
2,2,2-Trifluoro-1-(2-methoxyphenyl)ethanamine
Similarity: 0.78
[ 1810074-61-3 ]
(R)-6-(Trifluoromethoxy)chroman-4-amine hydrochloride
Similarity: 0.76
[ 730980-59-3 ]
(R)-Chroman-4-amine hydrochloride
Similarity: 0.76
[ 1392218-82-4 ]
(S)-6-Methylchroman-4-amine hydrochloride
Similarity: 0.76
[ 886368-62-3 ]
2,2,2-Trifluoro-1-(2-methoxyphenyl)ethanamine
Similarity: 0.78
[ 1810074-61-3 ]
(R)-6-(Trifluoromethoxy)chroman-4-amine hydrochloride
Similarity: 0.76
[ 2222471-40-9 ]
(S)-2,2,2-Trifluoro-1-(3-methoxyphenyl)ethanamine hydrochloride
Similarity: 0.75
[ 823782-74-7 ]
4-(2-(Trifluoromethyl)phenoxy)piperidine hydrochloride
Similarity: 0.73
[ 890839-66-4 ]
8-(Trifluoromethyl)chroman-4-one
Similarity: 0.71
[ 1810074-61-3 ]
(R)-6-(Trifluoromethoxy)chroman-4-amine hydrochloride
Similarity: 0.76
[ 730980-59-3 ]
(R)-Chroman-4-amine hydrochloride
Similarity: 0.76
[ 1392218-82-4 ]
(S)-6-Methylchroman-4-amine hydrochloride
Similarity: 0.76
[ 1035093-81-2 ]
(S)-Chroman-4-amine hydrochloride
Similarity: 0.76